Concepedia

Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients

Mitch Dowsett, FA MacNeill, AJ Mehta, C.J. Newton, Ben P. Haynes, AL Jones, Michael Jarman, TJ Powles, R. Charles Coombes

British Journal of Cancer · 1991 · 31 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

Richard J. Santen, Steven J. Santner, BONNIE DAVIS et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 341 citations

, , +17

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

, , +17

4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER

R. Charles Coombes, Mitch Dowsett, Paul E. Goss et al. · The Lancet · 1984 · 235 citations

, , +10

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

Adrian L. Harris, Mitch Dowsett, S.L. Jeffcoate et al. · The Journal of Clinical Endocrinology & Metabolism · 1982 · 99 citations

, , +17

Inhibition of Aromatase With CGS 16949A in Postmenopausal Women*

Richard J. Santen, Laurence M. Demers, Herman Adlercreutz et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 99 citations

, , +17